StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2021 - 12 - 13
14
2021 - 12 - 12
1
Sector
Health technology
13
Manufacturing
1
Tags
Acquisition
16
Acquisition corp
5
Alliances
5
Als
24
Approval
4
Authorization
4
Biopharma
5
Bioscience
5
Biotech
8
Biotech-bay
5
Cancer
10
Car-t
6
Clinical-trials-phase-ii
14
Collaboration
6
Conference
8
Contract
6
Covid
6
Covid-19
6
Drug
5
Ema
27
Energy
11
Europe
10
Events
8
Fda
5
Genetown
5
Grant
6
Granted
7
Growth
6
Health
10
Index
9
Iot
13
Ipo
5
Liver
6
N/a
282
Nasdaq
11
Offering
9
Partnership
9
People
11
Pharm-country
6
Phase 1
13
Phase 2
10
Phase 2b
5
Phase 3
7
Platform
9
Positive
19
Potential
6
Pre-clinical
10
Preclinical
10
Presentation
8
Research
24
Response
5
Results
19
T-cell
10
Technology
14
Test
10
Therapeutics
33
Therapy
12
Treatment
15
Trial
28
Trials
5
Entities
4d pharma plc - adr
1
Abbvie inc.
1
Bellus health inc.
1
Coherus biosciences, inc.
1
Compass pathways plc
1
Electrocore, inc.
1
Gilead sciences, inc.
1
Intellia therapeutics, inc.
1
Jazz pharmaceuticals plc
1
Johnson & johnson
1
Medicinova, inc.
1
Nuvation bio inc - class a
1
Rocket pharmaceuticals, inc.
1
Teleflex incorporated
1
Veru inc.
1
X4 pharmaceuticals, inc.
1
Symbols
ABBV
1
BLU
1
CHRS
1
CMPS
1
ECOR
1
GILD
1
JAZZ
1
JNJ
1
LBPS
1
MNOV
1
NTLA
1
NUVB
1
RCKT
1
TFX
1
VERU
1
XFOR
1
Exchanges
Nasdaq
12
Nyse
4
Crawled Date
2024 - 03 - 19
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
12
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
14
2023 - 06 - 26
13
2023 - 04 - 25
13
2023 - 04 - 17
14
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
14
2022 - 11 - 17
12
2022 - 10 - 12
13
2022 - 09 - 14
12
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 29
11
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 07 - 13
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 04 - 30
11
2021 - 04 - 15
11
2021 - 03 - 22
14
2020 - 12 - 15
14
2020 - 12 - 03
11
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
00:00
1
08:00
2
12:30
2
13:00
1
14:00
1
14:30
2
15:00
1
15:30
1
21:00
1
22:00
2
23:00
1
Source
www.4dpharmaplc.com
1
www.biospace.com
10
www.globenewswire.com
2
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
crawled date :
2021 - 12 - 13
save search
Teleflex Receives Reimbursement Approval for the UroLift® System in JapanWill expand patient access to breakthrough BPH treatment
Published:
2021-12-13
(Crawled : 23:00)
- biospace.com/
TFX
|
$207.27
0.34%
0.0%
330K
|
Health Technology
|
-35.49%
|
O:
-0.09%
H:
0.0%
C:
0.0%
urolift
treatment
approval
COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study
Published:
2021-12-13
(Crawled : 22:00)
- biospace.com/
CMPS
|
$8.36
-0.24%
-0.6%
350K
|
Health Technology
|
-68.32%
|
O:
-5.04%
H:
0.0%
C:
0.0%
comp360
treatment
positive
therapy
depression
psilocybin
Yescarta® ZUMA-12 Study Demonstrates 78% Complete Response Rate as Part of First-Line Treatment in Newly Diagnosed High-Risk Large B-Cell Lymphoma
Published:
2021-12-13
(Crawled : 22:00)
- biospace.com/
GILD
|
$66.95
0.29%
0.28%
3.8M
|
Health Technology
|
-4.6%
|
O:
-0.09%
H:
0.0%
C:
0.0%
zuma-12
yescarta
treatment
risk
t-cell
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
35.53%
|
O:
1.07%
H:
0.0%
C:
0.0%
CHRS
|
$2.18
5.31%
5.48%
1.3M
|
Health Technology
|
-87.03%
|
O:
-0.83%
H:
0.0%
C:
0.0%
hoice-01
treatment
trial
lung cancer
positive
therapy
bioscience
results
cancer
phase 3
Veru Announces FDA Approval of ENTADFI, a New Treatment for Benign Prostatic Hyperplasia
Published:
2021-12-13
(Crawled : 15:30)
- biospace.com/
VERU
|
$1.27
-3.05%
-3.15%
1.3M
|
Health Technology
|
-79.68%
|
O:
9.28%
H:
0.0%
C:
0.0%
treatment
fda
fda approval
approval
Rocket Pharmaceuticals Presents Positive Clinical Data from Company’s Lentiviral Gene Therapies for Treatment of Fanconi Anemia, LAD-I and PKD at the 63rd American Society of Hematology (ASH) Annual Meeting
Published:
2021-12-13
(Crawled : 15:00)
- biospace.com/
RCKT
M
|
$23.87
4.69%
4.64%
430K
|
Health Technology
|
5.11%
|
O:
1.14%
H:
0.0%
C:
0.0%
treatment
ema
als
anemia
gene therapies
positive
gene therapy
X4 Pharmaceuticals Presents New Clinical and Scientific Data at 2021 ASH Annual Meeting Supporting Broader Potential for Mavorixafor in the Treatment of Primary Immunodeficiencies
Published:
2021-12-13
(Crawled : 14:30)
- biospace.com/
XFOR
|
$1.36
7.94%
6.67%
2.3M
|
Health Technology
|
-65.57%
|
O:
-25.95%
H:
0.0%
C:
0.0%
treatment
als
potential
Intellia Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of NTLA-2002 for the Treatment of Hereditary Angioedema
Published:
2021-12-13
(Crawled : 14:30)
- biospace.com/
NTLA
|
$21.83
1.21%
1.28%
1M
|
Health Technology
|
-80.85%
|
O:
1.12%
H:
0.0%
C:
0.0%
ntla-2002
treatment
ema
trial
therapeutics
intel
phase 1
hereditary angioedema
electroCore Announces New Patent for Stroke and TIA Treatment
Published:
2021-12-13
(Crawled : 14:00)
- globenewswire.com
ECOR
|
$5.62
-0.53%
4.88%
6.7K
|
Health Technology
|
649.33%
|
O:
2.03%
H:
0.0%
C:
0.0%
treatment
patent
stroke
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer
Published:
2021-12-13
(Crawled : 13:00)
- biospace.com/
NUVB
|
$2.68
3.08%
4.85%
1.1M
|
|
-70.45%
|
O:
-0.11%
H:
0.0%
C:
0.0%
nuv-422
new drug
treatment
fda
clearance
prostate cancer
application
drug
fda clearance
cancer
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of ALS
Published:
2021-12-13
(Crawled : 12:30)
- biospace.com/
MNOV
|
$1.34
-3.6%
-3.73%
17K
|
Health Technology
|
-57.46%
|
O:
2.22%
H:
0.0%
C:
0.0%
mn-166
treatment
patent
als
parkinson
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
Published:
2021-12-13
(Crawled : 12:30)
- biospace.com/
BLU
|
$14.74
0.03%
0
|
Health Technology
|
153.26%
|
O:
35.91%
H:
0.0%
C:
0.0%
blu-5937
treatment
health
phase 2
phase 2b
trial
topline results
positive
results
topline
chronic cough
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma
Published:
2021-12-13
(Crawled : 08:00)
- 4dpharmaplc.com
LBPS
|
$1.65
-0.61%
|
Manufacturing
|
-74.22%
|
O:
-4.06%
H:
0.0%
C:
0.0%
dp0004
treatment
trial
topline results
positive
results
topline
PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer
Published:
2021-12-13
(Crawled : 08:00)
- prnewswire.com
JAZZ
|
$108.83
-1.01%
-1.04%
510K
|
Health Technology
|
-12.42%
|
O:
-1.06%
H:
0.0%
C:
0.0%
zepzelca
treatment
trial
lung cancer
cancer
phase 3
New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
Published:
2021-12-12
(Crawled : 00:00)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-10.04%
|
O:
-0.41%
H:
0.0%
C:
0.0%
treatment
cel
Gainers vs Losers
73%
27%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
ATGL
|
$2.86
46.25%
32.8%
180K
|
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
PROK
|
$2.72
33.33%
24.58%
2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.